Should bipolar disorder treatment be modified depending on staging?

References

• Yatham LN, Kennedy SH, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord. 2013;15:1–44. ​
   PubMed Web of Science ®Google Scholar
• Passos IC, Mwangi B, Vieta E, et al. Areas of controversy in neuroprogression in bipolar disorder. Acta Psychiatr Scand. 2016;134:91–103.
   PubMed Web of Science ®Google Scholar
• Samalin L, de Chazeron I, Vieta E, et al. Residual symptoms and specific functional impairments in euthymic patients with bipolar disorder. Bipolar Disord. 2016;18:164–173.
   PubMed Web of Science ®Google Scholar
• De Fruyt J, Deschepper E, Audenaert K, et al. Second generation antipsychotics in the treatment of bipolar depression: a systematic review and meta-analysis. J Psychopharmacol. 2012;26:603–617.
   PubMed Web of Science ®Google Scholar
• Kapczinski F, Dias VV, Kauer-Sant’Anna M, et al. Clinical implications of a staging model for bipolar disorders. Expert Rev Neurother. 2009;9:957–966.
   PubMed Web of Science ®Google Scholar
• Berk M, Conus P, Lucas N, et al. Setting the stage: from prodrome to treatment resistance in bipolar disorder. Bipolar Disord. 2007;9:671–678.
   PubMed Web of Science ®Google Scholar
• Rosa AR, Magalhães PVS, Czepielewski L, et al. Clinical staging in bipolar disorder: focus on cognition and functioning. J Clin Psychiatry. 2014;75:e450–e456.
   PubMed Web of Science ®Google Scholar
• Da Costa SC, Passos IC, Lowri C, et al. Refractory bipolar disorder and neuroprogression. Prog Neuropsychopharmacol Biol Psychiatry. 2015;70:103–110.
   PubMed Web of Science ®Google Scholar
• Swann AC, Bowden CL, Calabrese JR, et al. Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania. Am J Psychiatry. 1999;156:1264–1266.
   PubMed Web of Science ®Google Scholar
• Scott J, Paykel E, Morriss R, et al. Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial. Br J Psychiatry. 2006;188:313–320.
   PubMed Web of Science ®Google Scholar
• Berk M, Brnabic A, Dodd S, et al. Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention. Bipolar Disord. 2011;13:87–98.
   PubMed Web of Science ®Google Scholar
• Obrocea GV, Dunn RM, Frye MA, et al. Clinical predictors of response to lamotrigine and gabapentin monotherapy in refractory affective disorders. Biol Psychiatry. 2002;51:253–260.
   PubMed Web of Science ®Google Scholar
• Colom F, Reinares M, Pacchiarotti I, et al. Has number of previous episodes any effect on response to group psychoeducation in bipolar patients? A 5-year follow-up post hoc analysis. Acta Neuropsychiatr. 2010;22:50–53.
   PubMed Web of Science ®Google Scholar
• Reinares M, Colom F, Rosa AR, et al. The impact of staging bipolar disorder on treatment outcome of family psychoeducation. J Affect Disord. 2010;123:81–86.
   PubMed Web of Science ®Google Scholar
• Goi PD, Bücker J, Vianna-Sulzbach M, et al. Pharmacological treatment and staging in bipolar disorder: evidence from clinical practice. Rev Bras Psiquiatr (São Paulo, Brazil). 1999;37:121–125.
   Google Scholar
• Baldessarini RJ, Tondo L, Hennen J. Treatment-latency and previous episodes: relationships to pretreatment morbidity and response to maintenance treatment in bipolar I and II disorders. Bipolar Disord. 2003;5:169–179.
   PubMed Web of Science ®Google Scholar
• Berghöfer A, Alda M, Adli M, et al. Long-term effectiveness of lithium in bipolar disorder: a multicenter investigation of patients with typical and atypical features. J Clin Psychiatry. 2008;69:1860–1868.
   PubMed Web of Science ®Google Scholar
• Rybakowski JK. Response to lithium in bipolar disorder: clinical and genetic findings. ACS Chem Neurosci. 2014;5:413–421.
   PubMed Web of Science ®Google Scholar
• Tohen M, Hennen J, Zarate CM, et al. Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am J Psychiatry. 2000;157:220–228.
   PubMed Web of Science ®Google Scholar
• Torrent C, Bonnin C, Del M, et al. Efficacy of functional remediation in bipolar disorder: a multicenter randomized controlled study. Am J Psychiatry. 2013;170:852–859.
   PubMed Web of Science ®Google Scholar
• Bonnin CM, Torrent C, Arango C, et al. Functional remediation in bipolar disorder: 1-year follow-up of neurocognitive and functional outcome. Br J Psychiatry. 2016;208:87–93.
   PubMed Web of Science ®Google Scholar
• Bonnin CM, Reinares M, Martínez-Arán A, et al. Effects of functional remediation on neurocognitively impaired bipolar patients: enhancement of verbal memory. Psychol Med. 2016;46:291–301.
   PubMed Web of Science ®Google Scholar
• Li X-B, Tang Y-L, Wang C-Y, et al. Clozapine for treatment-resistant bipolar disorder: a systematic review. Bipolar Disord. 2014;3:235–247.
   Google Scholar
• Gitlin M. Treatment-resistant bipolar disorder. Mol Psychiatry. 2006;11:227–240.
   PubMed Web of Science ®Google Scholar
• Poon SH, Sim K, Sum MY, et al. Evidence-based options for treatment-resistant adult bipolar disorder patients. Bipolar Disord. 2012;14:573–584.
   PubMed Web of Science ®Google Scholar
• Flanagan RJ. Side effects of clozapine and some other psychoactive drugs. Curr Drug Saf. 2008;3:115–122.
   PubMedGoogle Scholar
• Young AH, Gallagher P, Watson S, et al. Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder. Neuropsychopharmacology. 2004;29:1538–1545.
   PubMed Web of Science ®Google Scholar
• Miskowiak KW, Ehrenreich H, Christensen EM, et al. Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial. J Clin Psychiatry. 2014;75:1347–1355.
   PubMed Web of Science ®Google Scholar
• Naismith SL, Redoblado-Hodge MA, Lewis SJG, et al. Cognitive training in affective disorders improves memory: a preliminary study using the NEAR approach. J Affect Disord. 2010;121:258–262.
   PubMed Web of Science ®Google Scholar
• Demant KM, Vinberg M, Kessing LV, et al. Effects of short-term cognitive remediation on cognitive dysfunction in partially or fully remitted individuals with bipolar disorder: results of a randomised controlled trial. Scott JG, editor. PLoS One. 2015;10:e0127955.
   Web of Science ®Google Scholar
• Miskowiak KW, Carvalho AF, Vieta E, et al. Cognitive enhancement treatments for bipolar disorder: a systematic review and methodological recommendations. Eur Neuropsychopharmacol. 2016;26:1541–1561.
   PubMed Web of Science ®Google Scholar
• Alda M, Kapczinski F. Staging model raises fundamental questions about the nature of bipolar disorder. J Psychiatry Neurosci. 2016;41:291–293.
   PubMed Web of Science ®Google Scholar
• Alda M, Kapczinski F. Concepts and misconceptions regarding clinical staging models: author response. J Psychiatry Neurosci. 2016;41:E84–E85.
   Web of Science ®Google Scholar
• Shah J, Scott J. Concepts and misconceptions regarding clinical staging models. J Psychiatry Neurosci. 2016;41:E83–E84.
   PubMed Web of Science ®Google Scholar